Standout Papers

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of p... 2016 2026 2019 2022 387
  1. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer (2016)
    Thomas A. Mace, Reena Shakya et al. Gut

Immediate Impact

5 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
1 intermediate paper

Works of Christopher McQuinn being referenced

A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
2021
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
2016 Standout

Author Peers

Author Last Decade Papers Cites
Christopher McQuinn 327 40 184 100 5 420
Emily Nordquist 308 36 183 124 5 451
Thaiz Rivera Vargas 254 27 228 103 9 417
Yongshuai Jiang 282 45 186 170 6 495
Dmitrij Ostroumov 321 31 283 132 6 509
Pauline Maby 321 44 178 115 7 449
Christopher Taylor 177 28 205 151 6 487
Ashley Velez-Delgado 301 39 269 158 7 473
J. Kebbeh Darpolor 310 31 186 154 5 430
Vui Pham 272 27 157 220 5 441
Yoshihisa Arita 340 43 231 121 7 452

All Works

Loading papers...

Rankless by CCL
2026